Archer Daniels Midland Company (ADM) Barclays 19th Annual Global Consumer Conference summary

Financial performance and outlook

• Adjusted EPS for Q2 reached $1.84, with first-half adjusted EPS up 50% year-over-year, reflecting strong execution across all business segments.

• Nutrition business grew approximately 50% in operating profit in Q2, AS&O over 100%, and Carbs also performed strongly, aided by ethanol and policy incentives.

• Guidance for full-year adjusted EPS was raised to $5.15–$5.60, with leverage expected around 2x by year-end and CapEx in the $1.3–$1.5 billion range.

• Dividend payments continue for the 379th consecutive quarter, and modest share repurchases have resumed.

• Q3 is expected to be stronger than Q4 due to booked margins and seasonality, with the second half anticipated to outperform the first.

Strategic growth drivers and innovation

• Flavors growth is driven by customer focus, operational excellence, and integration of acquisitions, with strong performance in emerging markets and ongoing investments in core capabilities.

• The shift to natural colors in the U.S. is targeted to generate $80–$100 million in operating profit, leveraging experience from Europe and incremental capacity investments.

• Growth platforms include decarbonization, biosolutions, functional health, advanced nutrition, and precision fermentation, supported by existing infrastructure and customer relationships.

• Investments in AI and digital tools are enhancing commercial and operational efficiency, particularly in Nutrition.

• The company is pursuing bolt-on M&A and prioritizing organic growth and productivity initiatives for capital allocation.

Operational efficiency and cost management

• A cost-saving program aims to achieve $500–$750 million in savings over three to five years, focusing on SG&A, procurement, manufacturing efficiency, and transaction costs.

• Lean initiatives in finance and IT have reduced accounts payable costs by 25% and streamlined vendor relationships.

• Debottlenecking efforts in existing plants are prioritized over greenfield projects, with $100 million invested to add 700,000 metric tons of capacity in North America.

• Portfolio rationalization and plant improvements in Nutrition have improved supply reliability and margin recovery, with a focus on high-growth, high-margin segments.

• The company maintains a strong cash position and stable credit ratings, enabling flexibility for future investments and shareholder returns.